Industry & Business

Alexion Pharmaceuticals investing €100m into biologics facility in Athlone

 Breaking News
  • MSD Announces New Manufacturing Facility and 170 New Jobs For Carlow MSD, known as Merck in the US and Canada, has announced that it will construct a second manufacturing facility at its existing site in Carlow with the creation of 170 new jobs. The new facility will focus on the production of vaccines and biologics and is scheduled to commence manufacturing operations in 2023. The build will include an [...]...
  • €100 Million Investment For Four Capital Developments at Trinity College Dublin Teaching, research and student accommodation at Trinity College Dublin will be transformed over the next two years with the backing of a €100 million long-term European Investment Bank (EIB) loan for four capital developments across the campus. This will include the flagship E3-Engineering, Environment and Emerging Technologies initiative at Trinity. Central to the vision of E3 [...]...
  • SSE Airtricity and Verde LED Light the Way to Energy Savings in New Partnership SSE Airtricity, Ireland’s leading provider of 100% green energy, has announced a new exclusive partnership with Verde LED to provide LED lighting upgrades and energy-efficiency improvements to businesses across Ireland. Verde LED, founded in 2010, specialises in lighting design for new and existing facilities, with a dedicated research and development (R&D) department to ensure product [...]...
  • AMI One of Only Four IT Disposal Companies Globally to Achieve Highest Industry Mark AMI, Ireland’s leading secure IT disposal company, has announced that it is the only company in Ireland to achieve an ADISA membership, and one of only four companies globally to attain the highest award, a Distinction with Honours. Both AMI’s Belfast and Dublin sites achieved the certification, making it the most secure IT disposal company on [...]...
  • Greencore to Divest US Business in $1 Billion Deal Greencore Group, the Irish and UK convenience food business, has agreed to sell its entire US business to an affiliate of Hearthside Food Solutions for US$1.075 billion (£817 million) on a cash and debt-free basis. Hearthside is a major US contract food manufacturer with a heritage in US food industry outsourcing. The disposal will leave [...]...

Alexion Pharmaceuticals investing €100m into biologics facility in Athlone

July 07
11:01 2016

download

 

 

US-headquartered biopharmaceutical company Alexion Pharmaceuticals is to invest €100m in a new biologics manufacturing facility in its Athlone operations which will result in the creation of 50 additional jobs. This will bring total employment at the plant to more than 100 people. The investment will see the construction of a new biologics manufacturing facility at the site.
Commenting on the announcement, Alexion’s Executive Vice President of Global Operations Julie O’Neill said: “Ireland is a key location for Alexion’s global operations and we are committed to further developing our manufacturing facilities in the country to support increasing production needs of our highly innovative and life-transforming therapies.”

Alexion has been in Athlone since 2014 and the current site there houses a vial fill-finish facility.

Alexion is also currently constructing a large-scale bulk biologics manufacturing facility at its Dublin site in College Park.

Between its facilities in Athlone and College Park, Alexion currently employs over 250 people in Ireland, and expects to continue to grow to almost 500 employees by the end of 2019.

Alexion has announced investments totalling €600 million in Ireland since 2014.

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4